The University of Melbourne/Cochlear Corporation (Nucleus) program.
The Nucleus multichannel cochlear prosthesis has been implanted in over 100 patients. Speech discrimination improved greatly in most patients. Overall, the results with this type of implant are very satisfactory.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001315:Australia; D001672:Biocompatible Materials; D002415:Cats; D002986:Clinical Trials as Topic; D003051:Cochlea / Q000293:injuries; D003054:Cochlear Implants / Q000009:adverse effects; D003638:Deafness / Q000175:diagnosis / Q000534:rehabilitation*; D004869:Equipment Safety; D006801:Humans; D007759:Labyrinth Diseases / Q000209:etiology; D008875:Middle Aged; D010033:Otitis Media / Q000209:etiology; D011182:Postoperative Care; D011183:Postoperative Complications / Q000209:etiology; D011474:Prosthesis Design; D012306:Risk; D013063:Speech Discrimination Tests; D013067:Speech Perception; D013203:Staphylococcal Infections / Q000209:etiology
D001672:Biocompatible Materials